This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
Fagan AM, Shaw LM, Xiong C et al (2011) Comparison of analytical platforms for cerebrospinal fluid measures of β-amyloid 1-42, total tau, and p-tau181 for identifying Alzheimer disease amyloid plaque pathology. Arch Neurol 68:1137–1144
Lahiri DK, Maloney B (2010) Beyond the signaling effect role of amyloid-β42 on the processing of APP, and its clinical implications. Exp Neurol 225:51–54
Nussbaum JM, Seward ME, Bloom GS (2013) Alzheimer disease. A tale of two prions. Prion 7:14–19
Rösler N, Wichart I, Jellinger KA (2002) Aktuelle klinisch-neurochemische Diagnostik der Alzheimer-Krankheit. J Lab Med 26:139–148
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature
About this chapter
Cite this chapter
Fiedler, H. (2019). β-Amyloidpeptide. In: Gressner, A.M., Arndt, T. (eds) Lexikon der Medizinischen Laboratoriumsdiagnostik. Springer Reference Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-48986-4_3404
Download citation
DOI: https://doi.org/10.1007/978-3-662-48986-4_3404
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-48985-7
Online ISBN: 978-3-662-48986-4
eBook Packages: Medicine (German Language)